Drawing for ONCASEPEG

USPTO serial 75352728

ONCASEPEG

Reviewed by CopyMark Law Group

Reg. 2261542Status 710
Filing date
Status date
Registration date
Jul 13, 1999
Examiner
HAMILTON, MICHAEL
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ONCASEPEG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JENNIFER LEE TAYLOR

JENNIFER LEE TAYLOR Morrison & Foerster LLP425 Market StreetSan Francisco, CA 94105-2482UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005therapeutic composition containing reagents for in vivo anticancer useSECTION 8 - CANCELLEDMar 18, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 23, 2009RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jul 23, 200989AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jul 17, 2009PLGLASSIGNED TO PARALEGAL
Jul 10, 2009E89RTEAS SECTION 8 & 9 RECEIVED
Jul 6, 2007CFITCASE FILE IN TICRS
Sep 13, 2005C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 12, 2005PLGLASSIGNED TO PARALEGAL
Jul 12, 2005815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jul 12, 2005E815TEAS SECTION 8 & 15 RECEIVED
Jul 13, 1999R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 1999CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 27, 1999DOCKASSIGNED TO EXAMINER
Apr 16, 1999SUPCSTATEMENT OF USE PROCESSING COMPLETE
Mar 22, 1999IUAFUSE AMENDMENT FILED
Sep 22, 1998NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 1998NPUBNOTICE OF PUBLICATION
Apr 29, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 1998CNEAEXAMINER'S AMENDMENT MAILED
Apr 18, 1998DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance